Columbia Care Prepares For The Introduction Of Whole Flower Program, Starts Cultivation at 34-Acre New York Facility
The 34-acre land in Long Island, New York, has started seeing the commencement of Columbia Care’s cultivation program. Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) plans to harvest the first set in the fourth quarter of 2021. The company commenced its cultivation program only after it received the necessary approvals from the New York State Department of Health.
About Columbia Care
Columbia Care is one of the leading players in the cannabis market of the U.S. Its name is well-known in the market for providing the original quality of cannabis products. The company primarily deals in the sectors of cultivation, manufacturing, and supplying cannabis products.
It currently holds the license to operate in 18 jurisdictions of the U.S. and the European Union. Columbia Care operates a total of 130 facilities across all its licensed regions. These facilities include 99 dispensaries and 31 cultivation & manufacturing facilities. Some of them are being developed and are expected to be operational at the earliest.
The company provides cannabis products to all the members of its community. Its community is a mix of patients and adults. Columbia Care provides cannabis products for medical purposes and recreational purposes. The products are supplied through its retail brand called Cannabist, which was set up in the current year.
The brands manufactured by Columbia Care include Triple Seven, Seed & Strain, gLeaf, Press, Classix, Platinum Label CBD, and Amber. The portfolio of its products includes spanning flower, oils, edibles, and tablets.
Columbia Care released an official press statement announcing that it has commenced the operations related to the cultivation of cannabis products on the land spread across 34-acre. This would be conducted in Long Island, New York. The commencement falls in line with the company’s plan to introduce the Whole Flower Program in the market.
The commencement was initiated after the company received approval from the New York State Department of Health. Columbia Care plans to harvest the first portion in the fourth quarter of the current year.
Nicholas Vita, the CEO of Columbia Care, said that he was grateful for the support that the company had received throughout the process of expansion and commencement. He added that while the residents of New York prepare themselves for the new product to arrive, the company would be all set to meet the deliverables through its scaled operations and centrally structured management.
New York is expected to become the largest market for cannabis products. Nicholas Vita appreciated the local leadership team of Columbia Care for taking swift action in creating the foundation in New York. He also said that the current actions of the company will encourage the market to become legal and more accessible for medical and adult-use purposes.
The location where the operations have commenced is Riverhead, the acquisition of which was announced in April 2021. The overall area will be utilized in three different phases. The first phase has an area of 30,000 square feet that will be utilized to initiate the harvest cycle. This would begin to happen by the end of 2021.
The subsequent phases, or second phase and third phase, will utilize 740,000 square feet and 200,000 square feet, respectively. The first phase would deal with operational greenhouse space and the second phase would deal with the incremental grow capacity. This expansion is expected to support the estimated rise in the medical market of cannabis products.
Columbia Care also plans to provide the space to its potential partners who may collaborate in the future.
The operations in the expanded region will serve the existing four dispensaries of Columbia Care in New York. Additionally, it will also take on the responsibility of acting as a wholesale distributor to the entire market of New York.